查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951298

臨床檢測市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、最終用戶、地區和競爭格局分類，2021-2031年）

Clinical Laboratory Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臨床檢測市場預計將從 2025 年的 1,272.4 億美元成長到 2031 年的 2,144.5 億美元，複合年成長率為 9.09%。

這些專業的醫學評估包括分析尿液、血液和組織等生物檢體，以識別、診斷和追蹤疾病的進展。市場成長的主要驅動力是全球慢性病（例如糖尿病和心血管疾病）盛行率的不斷上升，這些疾病需要頻繁且細緻的監測。此外，人口老化加劇也推動了對診斷服務的需求，因為老年人通常需要更密集的醫療管理。這些人口和流行病學因素為檢測量的成長奠定了堅實的基礎，確保了市場持續成長，且這種成長不依賴任何特定的技術趨勢。

市場概覽
預測期 2027-2031
市場規模：2025年 1272.4億美元
市場規模：2031年 2144.5億美元
複合年成長率：2026-2031年 9.09%
成長最快的細分市場 糖化血紅素 (HbA1c) 檢測
最大的市場 北美洲

然而，市場擴張的一大障礙是合格實驗室技術人員的嚴重短缺，這限制了營運擴充性和檢測能力。人才短缺造成了瓶頸，阻礙了檢查室高效處理日益成長的檢體量。根據美國臨床病理學會的數據，到2025年，解剖病理科的空缺率將達到28.5%。這種人員短缺可能導致診斷結果延遲，並限制基本服務的提供，這可能會阻礙全球臨床檢測市場的整體成長。

市場促進因素

診斷自動化技術的進步和人工智慧 (AI) 的整合正在提高工作流程效率和診斷準確性。檢查室正在加速採用人工智慧來管理複雜的生物數據並實現常規任務的自動化，這是在滿足日益成長的檢測量的同時減少人為干預的關鍵一步。這項技術進步也體現在監管領域，美國食品藥物管理局(FDA) 報告稱，截至 2024 年 8 月，已有 950 種支援人工智慧/機器學習的醫療設備核准。這些創新有助於減輕檢查室的…

私營和獨立臨床實驗室網路的擴張正透過策略整合推動進一步成長。大型商業診斷機構正積極開展醫院推廣計畫並收購小規模的區域實驗室，旨在集中檢測業務並最佳化供應鏈成本。這種大規模網路擴張的趨勢需要大量的資本投資。例如，Quest Diagnostics在2024年7月的新聞稿中宣布，已達成最終協議，將以約13.5億加元的價格收購總部位於加拿大的LifeLabs。此類整合確保了在全球市場持續擴充性，並維持了可觀的收入規模。羅氏診斷部門2024年上半年的銷售額達到72億瑞士法郎，便印證了這一點。

市場挑戰

合格實驗室技術人員的嚴重短缺嚴重限制了實驗室的運作能力，並嚴重阻礙了全球臨床檢測市場的發展。慢性病的高發生率推動了診斷檢測的需求，但由於缺乏足夠的合格人員來檢驗結果和管理複雜的流程，實驗室難以擴展服務。自動化雖然提高了效率，但並不能取代分析前和分析後階段熟練的監管人員。因此，人才短缺直接導致流程瓶頸和周轉時間延長，限制了創收檢測的總量，並削弱了市場需求成長帶來的潛在收入成長。

勞動力短缺加劇了營運負擔，威脅到實驗室服務的長期永續性。隨著經驗豐富的人才離開這個行業，培訓新員工和維持服務連續性的能力也隨之下降。根據美國臨床病理學會 (ASCP) 2025 年的一項調查，17 個實驗室部門中有 10 個報告稱其人員流動率高於歷史平均值。這種人員流動加速而補充人員不足的趨勢加劇了人員短缺危機，並確保服務可用性將繼續成為市場擴張的關鍵阻礙因素。

市場趨勢

家用自採試劑盒的日益普及正在從根本上改變患者的就醫方式，它分散了診斷流程，並賦予消費者管理自身健康的能力。這一趨勢使常規體檢不再局限於傳統的採血中心，患者可以在家中進行非侵入性檢體採集，用於檢測健康狀況指標和慢性病等各種疾病。診斷服務提供者正積極利用這一轉變，將市場需求旺盛的檢測項目添加到其面向消費者的產品組合中，從而在傳統醫生轉診之外開闢新的收入來源。例如，Quest Diagnostics公司公佈，截至2025年1月的會計年度，年收入達98.7億美元，主要得益於其主導消費者的檢測平台策略性擴張，目前已涵蓋約135項健康和保健檢測項目。

同時，個人化醫療和伴隨診斷的蓬勃發展正在改變檢測服務格局，它將先進的基因組學和分子檢測技術整合起來，以指導標靶治療介入。製藥公司和診斷試劑開發商正在協調各自的研發管線，以識別特定的生物標記物，並將患者與腫瘤和免疫治療方案相匹配。這使得高複雜度檢測成為臨床診療的常規組成部分。治療研發與診斷準確性之間的這種協同作用，即使在疫情導致檢測量下降的情況下，也為主要產業參與者維持了穩定的收入來源。根據羅氏於2025年1月公佈的2024會計年度全年財務業績，其診斷部門的銷售額達到143億瑞士法郎，核心業務成長8%，這主要得益於市場對用於高級臨床決策支持的免疫診斷和分子解決方案的強勁需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球臨床檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（血液常規檢查、血紅素/血球容積比測試、基礎代謝指標測試、尿素氮/肌酸酐測試、電解質測試、糖化血紅蛋白測試、綜合代謝指標測試、肝功能測試、血脂測試、腎功能測試、心血管測試）
    • 依最終使用者（中心檢查室、基層醫療診所）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美臨床檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臨床檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臨床檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臨床檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球臨床檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Quest Diagnostics Incorporated
  • Abbott Laboratories Inc.
  • Cinven Group
  • Laboratory Corporation of America Holdings
  • Arup Laboratories Inc.
  • Opko Health, Inc.
  • Unilabs Diagnostics AB
  • Clinical Reference Laboratory, Inc.
  • Synnovis Group Llp
  • Sonic Healthcare Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17184

The Global Clinical Laboratory Tests Market is projected to expand from USD 127.24 Billion in 2025 to USD 214.45 Billion by 2031, registering a CAGR of 9.09%. These specialized medical assessments involve the analysis of biological specimens, such as urine, blood, and tissue, to identify, diagnose, and track disease progression. Market growth is primarily fueled by the increasing global prevalence of chronic disorders, such as diabetes and cardiovascular conditions, which require frequent and precise monitoring. Additionally, the growing geriatric population drives demand for diagnostic services, as older adults typically necessitate more intensive healthcare management. These demographic and epidemiological factors establish a solid foundation for testing volumes, ensuring sustained growth independent of specific technological trends.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 127.24 Billion
Market Size 2031USD 214.45 Billion
CAGR 2026-20319.09%
Fastest Growing SegmentHbA1c Tests
Largest MarketNorth America

However, a significant obstacle to market expansion is the acute shortage of qualified laboratory professionals, which restricts operational scalability and testing capacity. This workforce gap creates bottlenecks that hinder the ability of laboratories to efficiently process rising sample volumes. Data from the American Society for Clinical Pathology indicates that in 2025, the vacancy rate for anatomic pathology departments stood at 28.5 percent. Such staffing deficiencies threaten to delay diagnostic results and impede the broader growth of the global clinical laboratory tests market by limiting the availability of essential services.

Market Driver

Technological progress in diagnostic automation and the integration of artificial intelligence is refining workflow efficiency and diagnostic accuracy. Laboratories are increasingly adopting AI to manage complex biological data and automate routine tasks, a crucial step for handling higher testing volumes with less manual intervention. This technological momentum is reflected in the regulatory landscape; the U.S. Food and Drug Administration reported in August 2024 that 950 AI/ML-enabled medical devices had been authorized. These innovations help alleviate workforce shortages while enabling the deployment of sophisticated diagnostic algorithms, ensuring labs can meet modern throughput demands.

The proliferation of private and independent clinical laboratory networks is further driving growth through strategic consolidation. Major commercial diagnostic entities are acquiring hospital outreach programs and smaller regional labs to centralize testing operations and optimize supply chain costs. This trend toward large-scale network expansion involves significant capital investment; for instance, Quest Diagnostics announced in a July 2024 press release a definitive agreement to acquire the Canadian provider LifeLabs for approximately CAN $1.35 billion. Such consolidation ensures the continued scalability of the global market, sustaining substantial revenue volumes, as evidenced by Roche's Diagnostics Division reporting half-year sales of CHF 7.2 billion in 2024.

Market Challenge

The severe shortage of qualified laboratory professionals places a hard ceiling on operational capacity, significantly hampering the Global Clinical Laboratory Tests Market. While the prevalence of chronic diseases drives up demand for diagnostic testing, laboratories cannot scale their services without sufficient certified personnel to validate results and manage complex workflows. Although automation enhances efficiency, it does not eliminate the need for skilled oversight during pre-analytical and post-analytical phases. Consequently, workforce deficits directly result in processing bottlenecks and extended turnaround times, which restricts the overall volume of monetizable tests and erodes potential revenue gains from rising market demand.

This operational strain is intensified by a shrinking workforce demographic that threatens the long-term sustainability of testing services. As experienced personnel leave the field, the capacity to train new recruits and maintain service continuity diminishes. According to the American Society for Clinical Pathology in 2025, 10 out of 17 laboratory departments reported rising retirement rates compared to previous cycles. This trend of accelerating retirements without adequate replacement deepens the staffing crisis, ensuring that service availability remains a primary constraint on market expansion.

Market Trends

The increasing utilization of at-home self-collection and sampling kits is fundamentally transforming patient access by decentralizing diagnostic workflows and empowering consumers to proactively manage their health. This trend shifts routine screening away from traditional phlebotomy centers, allowing patients to perform non-invasive sample collection for conditions ranging from wellness markers to chronic disease monitoring in private settings. Diagnostic providers are aggressively capitalizing on this shift by expanding their direct-to-consumer portfolios to include high-demand assays, creating new revenue channels that bypass traditional physician referrals. For example, Quest Diagnostics reported full-year revenues of $9.87 billion in its January 2025 financial results, a performance supported by the strategic expansion of its consumer-initiated test platform to include approximately 135 distinct health and wellness tests.

Concurrently, the growth of personalized medicine and companion diagnostics is altering laboratory service menus as providers integrate advanced genomic and molecular testing to guide targeted therapeutic interventions. Pharmaceutical and diagnostic developers are synchronizing their pipelines to ensure specific biomarkers can be identified to match patients with oncology and immunology treatments, thereby making high-complexity assays a standard component of clinical care. This synergy between therapeutic development and diagnostic precision sustains revenue streams for major industry players even as pandemic-related testing volumes decline. As reported in its 2024 full-year results released in January 2025, Roche's Diagnostics Division generated sales of CHF 14.3 billion, with the base business growing 8% largely due to strong demand for immunodiagnostic and molecular solutions supporting advanced clinical decision-making.

Key Market Players

  • Quest Diagnostics Incorporated
  • Abbott Laboratories Inc.
  • Cinven Group
  • Laboratory Corporation of America Holdings
  • Arup Laboratories Inc.
  • Opko Health, Inc.
  • Unilabs Diagnostics AB
  • Clinical Reference Laboratory, Inc.
  • Synnovis Group Llp
  • Sonic Healthcare Limited

Report Scope

In this report, the Global Clinical Laboratory Tests Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Laboratory Tests Market, By Type

  • Complete Blood Count
  • HGB/HCT Testing
  • Basic Metabolic Panel Testing
  • BUN Creatinine Testing
  • Electrolytes Testing
  • HbA1c Testing
  • Comprehensive Metabolic Panel Testing
  • Liver Panel Testing
  • Lipid Panel Testing
  • Renal Panel Testing
  • Cardiovascular Panel Tests

Clinical Laboratory Tests Market, By End User

  • Central Laboratories
  • Primary Clinics

Clinical Laboratory Tests Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Laboratory Tests Market.

Available Customizations:

Global Clinical Laboratory Tests Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Laboratory Tests Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Complete Blood Count, HGB/HCT Testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Lipid Panel Testing, Renal Panel Testing, Cardiovascular Panel Tests)
    • 5.2.2. By End User (Central Laboratories, Primary Clinics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Clinical Laboratory Tests Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Laboratory Tests Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Clinical Laboratory Tests Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Clinical Laboratory Tests Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Clinical Laboratory Tests Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Laboratory Tests Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Clinical Laboratory Tests Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Clinical Laboratory Tests Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Clinical Laboratory Tests Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Clinical Laboratory Tests Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Clinical Laboratory Tests Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Laboratory Tests Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Clinical Laboratory Tests Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Clinical Laboratory Tests Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Clinical Laboratory Tests Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Clinical Laboratory Tests Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Clinical Laboratory Tests Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Laboratory Tests Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Clinical Laboratory Tests Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Clinical Laboratory Tests Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. South America Clinical Laboratory Tests Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Laboratory Tests Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Clinical Laboratory Tests Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Clinical Laboratory Tests Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Laboratory Tests Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Quest Diagnostics Incorporated
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Cinven Group
  • 15.4. Laboratory Corporation of America Holdings
  • 15.5. Arup Laboratories Inc.
  • 15.6. Opko Health, Inc.
  • 15.7. Unilabs Diagnostics AB
  • 15.8. Clinical Reference Laboratory, Inc.
  • 15.9. Synnovis Group Llp
  • 15.10. Sonic Healthcare Limited

16. Strategic Recommendations

17. About Us & Disclaimer